• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Quality

    Emcure Rises as USFDA Issues Form 483 With Zero Observations

    BUSINESS STD

    Emcure Gets USFDA Form 483 With Two Observations For API Plant

    DAILYEXCELSIOR

    Indian pharma firms receive 34% of FDA warnings this year

    DOWNEARTH

    Emcure knocked by the FDA for sterility issues after injectable drug recall

    FIERCE PHARMA

    Emcure schizophrenia drug recalled after contamination spotted

    FIERCE PHARMA

    28 Unique Data Integrity Deficiencies That Aren’t Really Unique

    FDAZILLA

    Heritage Pharmaceuticals, Inc., Ongoing Class II recall of RIFAMPIN for Injection,USP, 600 mg per vial, Rx Only, Manufactured by: Emcure Pharmaceuticals Ltd., Hinjwadi, Pune, India Manufactured for: Heritage Pharmaceuticals Inc., Eatontown, NJ 07724 NDC 23155-340-31 because of Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.

    FDA

    Heritage Pharmaceuticals, Inc., Ongoing Class II recall of Colistimethate for Injection USP, 150 mg per vial, Rx Only, Manufactured by: Emcure Pharmaceuticals Ltd., Hinjwadi, Pune, India Manufactured for: Heritage Pharmaceuticals Inc. NDC 23155-193-31 because of Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.